Health systems around the world are finding themselves resilient after covid-19. The old paradigms are falling. A society where health is essential is then built.
Aware of the growing expectations of patients about their wellbeing, we are dedicating our efforts to building new avenues for the production of medicines, starting with cannabis-derived health products. This is why we created LaFleur, which determines this large-scale project to meet the needs of patients.